CymaBay Therapeutics Inc. (CBAY) Sees Large Growth in Short Interest

... company's stock worth $5,712,000 after purchasing an additional 170,126 shares during the last quarter. Finally, Ardsley Advisory Partners increased its position in CymaBay Therapeutics by 66.2% in the second quarter. Ardsley Advisory Partners now ...
http://ift.tt/2AzZVd0